HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 106 filers reported holding HERON THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $852,000 | -50.1% | 72,600 | 0.0% | 0.01% | -20.0% |
| Q4 2019 | $1,706,000 | +31.7% | 72,600 | +3.7% | 0.02% | +25.0% |
| Q3 2019 | $1,295,000 | -0.5% | 70,000 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $1,301,000 | -24.0% | 70,000 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $1,711,000 | -5.8% | 70,000 | 0.0% | 0.01% | -12.5% |
| Q4 2018 | $1,816,000 | -11.7% | 70,000 | +7.7% | 0.02% | +14.3% |
| Q3 2018 | $2,057,000 | -18.5% | 65,000 | 0.0% | 0.01% | -17.6% |
| Q2 2018 | $2,525,000 | +10.9% | 65,000 | -21.2% | 0.02% | +6.2% |
| Q1 2018 | $2,277,000 | +52.5% | 82,500 | 0.0% | 0.02% | +60.0% |
| Q4 2017 | $1,493,000 | +37.0% | 82,500 | +22.2% | 0.01% | +42.9% |
| Q3 2017 | $1,090,000 | +36.9% | 67,500 | +17.4% | 0.01% | +40.0% |
| Q2 2017 | $796,000 | -7.5% | 57,500 | -2.8% | 0.01% | +66.7% |
| Q1 2015 | $861,000 | -49.8% | 59,147 | -65.3% | 0.00% | -50.0% |
| Q4 2014 | $1,716,000 | – | 170,580 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |